Page last updated: 2024-12-05

6-methylsalicylic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

6-methylsalicylic acid: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

6-methylsalicylic acid : A monohydroxybenzoic acid that is salicylic acid in which the hydrogen ortho to the carboxylic acid group is substituted by a methyl group. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID11279
CHEMBL ID510026
CHEBI ID17637
SCHEMBL ID147955
MeSH IDM0046638

Synonyms (43)

Synonym
AC-5291
CHEBI:17637 ,
nsc 403256
brn 2208693
2,6-cresotic acid
benzoic acid, 2-hydroxy-6-methyl-
nsc-403256
6-ms
nsc403256
6-msa
6-hydroxy-o-toluic acid
C02657
6-methyl-2-hydroxybenzenecarboxylate
2-hydroxy-6-methylbenzoic acid
567-61-3
6-methylsalicylic acid
LMPK13010002
CHEMBL510026
AKOS004907081
A8114
2-hydroxy-6-methylbenzoicacid
unii-l5352fe23y
l5352fe23y ,
4-10-00-00594 (beilstein handbook reference)
FT-0600234
FS-2603
AM1081
SCHEMBL147955
MB01720
2-hydroxy-6-methyl-benzoic acid
SY030546
mfcd01194284
2-hydroxy-6-methylbenzoic acid #
DTXSID20205257
J-512620
J-509658
CS-W002751
BCP05389
Q6172528
GEO-04151
PD016989
EN300-105059
methylsalicylic acid, 6-
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
Penicillium metaboliteAny fungal metabolite produced during a metabolic reaction in Penicillium.
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
monohydroxybenzoic acidAny hydroxybenzoic acid having a single phenolic hydroxy substituent on the benzene ring.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID332912Antimicrobial activity Propionibacterium acnes ATCC 11827 after 2 days by broth dilution method1994Journal of natural products, Jan, Volume: 57, Issue:1
Naturally occurring antiacne agents.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (26)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (11.54)18.7374
1990's5 (19.23)18.2507
2000's10 (38.46)29.6817
2010's7 (26.92)24.3611
2020's1 (3.85)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 23.06

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index23.06 (24.57)
Research Supply Index3.33 (2.92)
Research Growth Index4.75 (4.65)
Search Engine Demand Index23.28 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (23.06)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (7.41%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other25 (92.59%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]